Dr Emma Parkinson-Lawrence
Program Director: Medical Sciences
School of Pharmacy and Biomedical Science
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Having been trained as a Biochemist and establishing a strong desire to work in the area of protein dysfunction and disease pathogenesis I was fortunate to obtain a research position in the Lysosomal Diseases Research Unit at the Women’s in Children’s Hospital. I became involved in research to understand the molecular mechanisms of lysosomal disease pathogenesis and developed diagnostic assays. During this time, I became particularly interested in the neurological dysfunction associated with these diseases, in particular Sanfilippo Syndrome, and commenced a research program looking at the role of altered neurotransmission and disease progression, having been awarded an NHMRC Peter Doherty Early Career Research Fellowship. At the completion of my fellowship I obtained a research-teaching academic position at the University of South Australia.
Serendipity and discussions with Professor Sandra Orgeig have evoked a new research program investigating the molecular mechanisms that may impact respiratory dysfunction in Sanfilippo Syndrome but may also contribute to other lysosomal diseases; underlying molecular mechanisms contributing to both neurological and respiratory dysfunction. This includes a continuing collaboration with Associate Kim Hemsley (Flinders University) and co supervision of PhD students. During my research career thus far, I have had the privilege to attend and present our research findings at several international MPS and related disease conferences and interacted with many amazing patients and their families, clinicians and scientists. This truly reinforces to me why I continue to do what I do.
As a senior scientist in the Mechanisms in Cell Biology and Disease research group I am also been involved in projects focussed on the endosome-lysosome system and cancer pathogenesis.
| Year | Citation |
|---|---|
| 2022 | Orgeig, S., Larcombe, A., Pinniger, G., Tsioutsias, I., & Parkinson-Lawrence, E. (2022). The mucopolysaccharide (MPS) I mouse displays lung and diaphragm dysfunction. In RESPIROLOGY Vol. 27 (pp. 63-64). WILEY. WoS1 |
| 2021 | Paget, T., Parkinson-Lawrence, E., Morrison, J., & Orgeig, S. (2021). THE MUCOPOLYSACCHARIDOSIS IIIA (MPS IIIA) MOUSE HAS DECREASED GENE AND PROTEIN EXPRESSION IN SURFACTANT PROTEINS - A, -C AND -D. In RESPIROLOGY Vol. 26 (pp. 140). WILEY. |
| 2021 | Paget, T., Larcombe, A., Parkinson-Lawrence, E., & Orgeig, S. (2021). THE MUCOPOLYSACCHARIDOSIS IIIA (MPS IIIA) MOUSE DEMONSTRATES INCREASED COMPLIANCE AND AIRWAY RESISTANCE AND DECREASED TISSUE DAMPING AND ELASTICITY. In RESPIROLOGY Vol. 26 (pp. 182). WILEY. |
| 2020 | Valtanen, P. G., Zhang, J., Scammell, A., Parkinson-Lawrence, E., Michael, M., Hussey, D., . . . Hayball, J. (2020). New polyclonal antibody therapeutic to treat esophageal adenocarcinoma and Barrett's esophagus by targeting EPHB4. In ANNALS OF ONCOLOGY Vol. 31 (pp. S167). ELECTR NETWORK: ELSEVIER. DOI |
| 2019 | Paget, T., Parkinson-Lawrence, E., Trim, P., Snel, M., & Orgeig, S. (2019). INCREASED HEPARAN SULPHATE AND DECREASED LIPIDS IN ALVEOLAR SURFACTANT OF THE MUCOPOLYSACCHARIDOSIS (MPS) IIIA MOUSE.. In RESPIROLOGY Vol. 24 (pp. 119). WILEY. WoS1 |
| 2019 | Orgeig, S., Larcombe, A., Paget, T., & Parkinson-Lawrence, E. (2019). THE MUCOPOLYSACCHARIDOSIS (MPS) IIIA MOUSE DEMONSTRATES INCREASED AIRWAYS RESISTANCE. In RESPIROLOGY Vol. 24 (pp. 99). WILEY. |
| 2017 | Bader, C. A., Sorvina, A., Brooks, R. D., Johnson, I. D., Carter, E., Lay, P., . . . Brooks, D. (2017). LIPID IMAGING IN PROSTATE CANCER.. In MOLECULAR BIOLOGY OF THE CELL Vol. 28 (pp. 2 pages). PA, Philadelphia: AMER SOC CELL BIOLOGY. |
| 2016 | Orgeig, S., Syedi, N., Duplock, S., Snel, M., Hemsley, K., & Parkinson-Lawrence, E. (2016). PULMONARY LIPID STORAGE AND LUNG ULTRASTRUCTURE IN THE MUCOPOLYSACCHARIDOSIS IIIA MOUSE. In RESPIROLOGY Vol. 21 (pp. 133). WILEY-BLACKWELL. |
| 2015 | Johnson, I. R. D., Parkinson-Lawrence, E. J., Butler, L. M., O'Leary, J. J., & Brooks, D. A. (2015). Altered Endosome Biogenesis in Prostate Cancer Has Prognostic Potential. In JOURNAL OF PATHOLOGY Vol. 237 (pp. S17). Univ Coll D, Dublin, IRELAND: WILEY-BLACKWELL. |
| 2005 | Parkinson-Lawrence, E., Muller, V., Hopwood, J., & Brooks, D. (2005). N-ACETYLGALACTOSAMINE 6-SULFATASE PROTEIN DETECTION IN MPS IVA PATIENTS. In JOURNAL OF INHERITED METABOLIC DISEASE Vol. 28 (pp. 190). SPRINGER. |
| 2005 | Parkinson-Lawrence, E., Hopwood, J., & Brooks, D. (2005). DIFFERENT LYSOSOMAL STORAGE DISORDERS CAN GENERATE DISTINCT VESICULAR COMPARTMENTS. In JOURNAL OF INHERITED METABOLIC DISEASE Vol. 28 (pp. 151). SPRINGER. |
| Year | Citation |
|---|---|
| 2016 | Brooks, D., Parkinson Lawrence, E., Johnson, I., Butler, L., & Weigert, R. (2016). EP3008210, Methods for detecting prostate cancer. |
-
Quantification of airway disease in MPS II mice via laboratory X-ray velocimetry, The National MPS Society (USA), 01/04/2024 - 31/03/2025
-
Diagnostic and prognostic biomarker test for prostate cancer, EnVision Sciences Pty Ltd, 01/01/2017 - 30/10/2018
-
Lung function in a mouse model of a paediatric metabolic mouse, The Australian Lung Foundation, 01/05/2016 - 05/03/2018
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 | Co-Supervisor | - | Doctor of Philosophy | Doctorate | Full Time | Miss Sammi Ngai |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2017 - 2021 | Co-Supervisor | Synaptic Morphology, Function, and Regulation in a Paediatric-Onset Neurodegenerative Disorder | Doctor of Philosophy | Doctorate | Full Time | Mr Andrew Peter Shoubridge |
Available For Media Comment.